Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neuroimmunol ; 363: 577789, 2022 02 15.
Artigo em Inglês | MEDLINE | ID: mdl-34973472

RESUMO

OBJECTIVE: The aim of this case report was to describe a potential anti-interleukin (IL)-6 treatment for cryptogenic new-onset refractory status epilepticus (C-NORSE). BACKGROUND: Although an underlying immune-mediated pathogenesis is considered present in some C-NORSE cases, many cases do not respond to classical immunotherapies. CASE REPORT: We describe the case of a 46-year-old woman with C-NORSE who achieved cessation of long-lasting status epilepticus following administration of tocilizumab, an IL-6 receptor-blocking antibody, although the final outcome was poor. CONCLUSIONS: Anti-IL-6 treatment may prove effective in stopping status epilepticus in some C-NORSE cases.


Assuntos
Anticorpos Monoclonais Humanizados/uso terapêutico , Epilepsia Resistente a Medicamentos/tratamento farmacológico , Interleucina-6/antagonistas & inibidores , Estado Epiléptico/tratamento farmacológico , Feminino , Humanos , Pessoa de Meia-Idade
3.
Rinsho Shinkeigaku ; 61(4): 258-261, 2021 Apr 21.
Artigo em Japonês | MEDLINE | ID: mdl-33762494

RESUMO

We report a 47-year-old woman who presented with progressive myalgia, weakness in the proximal limbs, and dysphagia for a month and a half. No skin rash was observed on admission. Examination of MRI data suggested inflammatory changes in the proximal limbs and trunk muscles. Biopsy specimens from the left biceps muscle showed no perifascicular atrophy, but immunohistochemical staining revealed the presence of myxovirus resistance protein A (MxA) in myofibers, strongly suggesting dermatomyositis (DM). In addition, her serum was positive for anti-nuclear matrix protein 2 (anti-NXP-2) antibody, which is reportedly useful as a marker of DM without skin lesions. Her symptoms gradually improved upon intravenous methylprednisolone pulse therapy in conjunction with oral prednisolone, oral tacrolimus, and intravenous immunoglobulin therapy. Our findings suggest that in cases where inflammatory muscle disease is suspected, anti-NXP-2 antibody analyses should be considered for precise diagnosis, even if there are no dermatological symptoms.


Assuntos
Adenosina Trifosfatases/imunologia , Anticorpos Antinucleares/metabolismo , Proteínas de Ligação a DNA/imunologia , Dermatomiosite/diagnóstico , Dermatomiosite/imunologia , Doenças Assintomáticas , Biomarcadores/metabolismo , Feminino , Humanos , Pessoa de Meia-Idade , Músculo Esquelético/metabolismo , Proteínas de Resistência a Myxovirus/metabolismo
4.
Rinsho Shinkeigaku ; 59(3): 153-156, 2019 Mar 28.
Artigo em Japonês | MEDLINE | ID: mdl-30814443

RESUMO

We analyzed 14 patients in our hospital, who underwent levodopa-carbidopa intestinal gel (LCIG) treatment through a percutaneous endoscopic gastrojejunostomy (PEG-J). The PEG-J related complications were observed in 10 patients (71.4%). Detailed complications are as followings: J-tube related complications such as kinking (3 cases, 21.4%), pump malfunctions (3 cases, 21.4%), skin troubles in the gastrostoma (7 cases, 50.0%), duodenal perforation, peritonitis, and ulcers (2 cases, 14.3%). These results indicated that the sufficient care for PEG-J associated complications are important in LCIG treatment.


Assuntos
Antiparkinsonianos/administração & dosagem , Carbidopa/administração & dosagem , Endoscopia Gastrointestinal/efeitos adversos , Gastrostomia/efeitos adversos , Jejunostomia/efeitos adversos , Levodopa/administração & dosagem , Doença de Parkinson/tratamento farmacológico , Adulto , Idoso , Combinação de Medicamentos , Duodenopatias/epidemiologia , Duodenopatias/etiologia , Úlcera Duodenal/epidemiologia , Úlcera Duodenal/etiologia , Endoscopia Gastrointestinal/instrumentação , Endoscopia Gastrointestinal/métodos , Feminino , Gastrostomia/instrumentação , Gastrostomia/métodos , Géis , Humanos , Perfuração Intestinal/epidemiologia , Perfuração Intestinal/etiologia , Jejunostomia/instrumentação , Jejunostomia/métodos , Masculino , Pessoa de Meia-Idade , Peritonite/epidemiologia , Peritonite/etiologia , Estudos Retrospectivos , Dermatopatias/epidemiologia , Dermatopatias/etiologia , Estomas Cirúrgicos
5.
Epilepsy Behav ; 92: 145-153, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30660057

RESUMO

PURPOSE: Cavernous malformation (CM) in the temporal neocortex causes intractable epilepsy. Whether to resect additional mesial temporal structures in addition to the lesionectomy is a still controversial issue. To clarify the need for the procedure, we retrospectively analyzed pre- and postoperative clinical data of patients with surgically removed CM. SUBJECTS AND METHODS: We included data from 18 patients with CM in the temporal neocortex who presented with intractable epilepsy. Eleven patients of our early series were treated with extended resection, i.e., lesionectomy and the resection of additional mesial temporal structures. Seven patients underwent lesionectomy, i.e., removal of the CM and of hemosiderin-stained surrounding brain tissue. Pathological assessments of the resected hippocampus were performed. Chronic intracranial electroencephalography (EEG) recordings were obtained in 6 patients. We performed perioperative neuropsychological assessments in all patients. RESULTS: The seizure outcome was recorded as Engel class I in 17 patients (94.4%); Ia = 12 (66.7%) Ib = 2 (11.1%), Ic = 1 (5.6%), Id = 2 (11.1%), and class IIb in one patient (5.6%). Adding resection of the mesial temporal structures to lesionectomy did not alter the seizure outcome. Pathology of hippocampus revealed limited neuronal loss in CA4. Ictal onsets in the ipsilateral lateral cortex were detected in all 6 patients who underwent intracranial EEG. In 4 patients each, we also detected ictal onsets from the ipsilateral mesial temporal structures and from the contralateral temporal lobe. Postoperatively, in the patients where their CM was located in the language-dominant hemisphere (n = 10), the full-scale intelligence quotient (IQ) and the performance IQ increased (p < 0.05), whereas the verbal memory (WMS-R) deteriorated in two of 5 patients. CONCLUSION: Excellent seizure outcomes were obtained even the lesionectomy alone. To confirm appropriate surgical strategy for lateral temporal CM with intractable epilepsy, further studies in large sample size are needed.


Assuntos
Epilepsia Resistente a Medicamentos/cirurgia , Epilepsia do Lobo Temporal/cirurgia , Hemangioma Cavernoso do Sistema Nervoso Central/cirurgia , Neocórtex/cirurgia , Convulsões/cirurgia , Lobo Temporal/cirurgia , Adulto , Epilepsia Resistente a Medicamentos/complicações , Epilepsia Resistente a Medicamentos/patologia , Epilepsia Resistente a Medicamentos/fisiopatologia , Eletroencefalografia/efeitos adversos , Epilepsia do Lobo Temporal/complicações , Feminino , Hemangioma Cavernoso do Sistema Nervoso Central/complicações , Hipocampo/patologia , Hipocampo/fisiopatologia , Hipocampo/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Convulsões/complicações , Convulsões/patologia , Convulsões/fisiopatologia , Lobo Temporal/patologia , Lobo Temporal/fisiopatologia , Adulto Jovem
6.
Rinsho Shinkeigaku ; 58(9): 570-573, 2018 Sep 28.
Artigo em Japonês | MEDLINE | ID: mdl-30175807

RESUMO

A 68-year-old man, who had received Billroth II gastrojejunostomy because of duodenal ulcer at the age of 20, was diagnosed to have Parkinson's disease at age 57 years. The drug therapy has been effective in the first 10 years, however, recently he was suffering from troublesome dyskinesia and wearing-off in spite of diligent drug adjustments. Although the indication of levodopa-carbidopa intestinal gel (LCIG) treatment was good, percutaneous endoscopic gastrostomy was difficult because of abdominal adhesion. Therefore, we introduced LCIG by surgical gastrostomy. After LCIG therapy, wearing-off and dyskinesia disappeared. This is the first case of Parkinson's disease patient with LCIG therapy by surgical gastrostomy in Japan.


Assuntos
Antiparkinsonianos/administração & dosagem , Carbidopa/administração & dosagem , Derivação Gástrica , Gastrostomia , Levodopa/administração & dosagem , Doença de Parkinson/tratamento farmacológico , Idoso , Formas de Dosagem , Combinação de Medicamentos , Composição de Medicamentos , Úlcera Duodenal/cirurgia , Géis , Humanos , Masculino , Resultado do Tratamento
7.
J Clin Neurophysiol ; 34(5): 427-433, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28557904

RESUMO

PURPOSE: Focal cortical dysplasia (FCD) is intrinsically epileptogenic, and an MRI-visible lesion typically constitutes the core part of the epileptogenic zone. We aimed to identify ictal EEG patterns that represent the epileptogenic zone by using subdural electrodes placed over the MRI-visible FCD lesion. METHODS: We selected seven patients with frontal lobe epilepsy caused by pathologically proven FCD type IIb who underwent preoperative intracranial EEG evaluation with subdural electrodes followed by resection surgery with seizure-free outcome. The characteristics of ictal EEG patterns, interictal/ictal high-frequency oscillations, and ictal direct current shifts from intracranial electrodes placed over the MRI-visible lesion were analyzed. RESULTS: Two seizure-onset patterns (low voltage fast activity and fast spike activity) were identified. Low voltage fast activity was seen in all patients with a lateral frontal lesion, and it was always preceded by preictal spikes. Fast spike activity occurred only in patients with a mesial frontal lesion. Interictal/ictal high-frequency oscillations and ictal direct current shifts were seen in all patients. CONCLUSIONS: The epileptogenic zone of frontal FCD type IIb may be characterized by EEG seizure-onset patterns consisting of low voltage fast activity and fast spike activity accompanied by ictal high-frequency oscillations and ictal direct current shifts. Further study is needed to determine whether other seizure-onset patterns exist in patients with FCD type IIb.


Assuntos
Eletrocorticografia/métodos , Epilepsia/fisiopatologia , Lobo Frontal/anormalidades , Lobo Frontal/fisiopatologia , Malformações do Desenvolvimento Cortical do Grupo I/fisiopatologia , Adulto , Epilepsia/complicações , Epilepsia/etiologia , Feminino , Humanos , Masculino , Malformações do Desenvolvimento Cortical do Grupo I/complicações , Pessoa de Meia-Idade , Adulto Jovem
8.
J Clin Neurophysiol ; 33(6): 564-568, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27295331

RESUMO

PURPOSE: Diagnosis of amyotrophic lateral sclerosis (ALS) at an early stage is challenging, thus making the enrollment of these patients in clinical trials infeasible. In this study, we investigated the potential usability of motor unit number index (MUNIX) to detect denervation of clinically intact muscles of ALS patients. METHODS: Thirty-two first dorsal interosseous muscles of 26 ALS patients were evaluated with both MUNIX and needle electromyography. RESULTS: The mean MUNIX value of first dorsal interosseous muscles was 131 in the control group, whereas it was 48, 34, 15, and 8 for Medical Research Council scales of 5, 4, 3, and 2, respectively, in the ALS patients. The optimal cutoff point gave a sensitivity of 0.89 and a specificity of 1.0. Among 9 intact first dorsal interosseous muscles of the ALS patients, 8 showed MUNIX values below the cutoff point, whereas only 2 first dorsal interosseous muscles showed denervation on needle electromyography. CONCLUSIONS: MUNIX could serve as a sensitive technique to detect denervation of clinically intact muscles of ALS patients.


Assuntos
Potencial Evocado Motor/fisiologia , Músculo Esquelético/inervação , Músculo Esquelético/fisiopatologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Esclerose Lateral Amiotrófica/diagnóstico , Eletromiografia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Condução Nervosa/fisiologia
10.
Rinsho Shinkeigaku ; 54(3): 223-6, 2014.
Artigo em Japonês | MEDLINE | ID: mdl-24705837

RESUMO

We report a case of reversible hepatic myelopathy. A 42-year-old female patient with 3-year history of alcoholic liver cirrhosis developed spastic gait, hyperreflexia and mild somatosensory disturbance in her lower extremities. The increased level of serum ammonia and the deficits of N30 and P38 in the tibial somatosensory evoked potentials (SEP) in conjunction with exclusion of the other known causes of myelopathy supported the diagnosis of her hepatic myelopathy. The ammonia lowering therapy by the oral administration of lactulose successfully improved the spastic gait accompanied with the emergence of N30 and P38 in the tibial SEP. Although liver transplantation was known to be the only therapy for hepatic myelopathy in the literatures, our case showed that the ammonia lowering therapy can be effective for the early stage of hepatic myelopathy.


Assuntos
Fármacos Gastrointestinais/administração & dosagem , Lactulose/administração & dosagem , Cirrose Hepática Alcoólica/complicações , Doenças da Medula Espinal/tratamento farmacológico , Doenças da Medula Espinal/etiologia , Administração Oral , Adulto , Amônia/sangue , Biomarcadores/sangue , Potenciais Somatossensoriais Evocados , Feminino , Humanos , Hiperamonemia/tratamento farmacológico , Hiperamonemia/etiologia , Transplante de Fígado , Doenças da Medula Espinal/diagnóstico , Tíbia/fisiopatologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...